Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Epigenome-wide analysis in newborn blood spots from monozygotic twins discordant for cerebral palsy reveals consistent regional differences in DNA methylation.

Mohandas N, Bass-Stringer S, Maksimovic J, Crompton K, Loke YJ, Walstab J, Reid SM, Amor DJ, Reddihough D, Craig JM.

Clin Epigenetics. 2018 Feb 23;10:25. doi: 10.1186/s13148-018-0457-4. eCollection 2018.

2.

Quality of life in young adults with cerebral palsy.

Jiang B, Walstab J, Reid SM, Davis E, Reddihough D.

Disabil Health J. 2016 Oct;9(4):673-81. doi: 10.1016/j.dhjo.2016.04.006. Epub 2016 May 3.

PMID:
27302534
3.

Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.

Walstab J, Wohlfarth C, Hovius R, Schmitteckert S, Röth R, Lasitschka F, Wink M, Bönisch H, Niesler B.

Neurogastroenterol Motil. 2014 Jun;26(6):810-20. doi: 10.1111/nmo.12334. Epub 2014 Apr 8.

PMID:
24708203
4.

Social outcomes of young adults with cerebral palsy.

Reddihough DS, Jiang B, Lanigan A, Reid SM, Walstab JE, Davis E.

J Intellect Dev Disabil. 2013 Sep;38(3):215-22. doi: 10.3109/13668250.2013.788690. Epub 2013 May 14.

PMID:
23672634
5.

Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons.

Walstab J, Krüger D, Stark T, Hofmann T, Demir IE, Ceyhan GO, Feistel B, Schemann M, Niesler B.

Neurogastroenterol Motil. 2013 May;25(5):439-47, e302. doi: 10.1111/nmo.12107. Epub 2013 Mar 12.

PMID:
23490018
6.

Immunisation coverage in children with cerebral palsy compared with the general population.

Greenwood VJ, Crawford NW, Walstab JE, Reddihough DS.

J Paediatr Child Health. 2013 Feb;49(2):E137-41. doi: 10.1111/jpc.12097. Epub 2013 Jan 29.

PMID:
23360148
7.

Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.

Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS.

J Craniofac Surg. 2013 Jan;24(1):28-33. doi: 10.1097/SCS.0b013e31827102a0.

PMID:
23348253
8.

Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.

Walstab J, Steinhagen F, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2011;63(1):45-53.

9.

Is this the last word on 'an unfortunate experiment'? Urinary oestriol assay for monitoring fetoplacental function. 1991.

Ellwood D, Beischer N, Brown J, Parkinson P, Walstab J.

Aust N Z J Obstet Gynaecol. 2010 Aug;50(4):309-17. doi: 10.1111/j.1479-828X.2010.01203.x. No abstract available.

PMID:
20716257
10.

5-HT(3) receptors: role in disease and target of drugs.

Walstab J, Rappold G, Niesler B.

Pharmacol Ther. 2010 Oct;128(1):146-69. doi: 10.1016/j.pharmthera.2010.07.001. Epub 2010 Jul 16.

PMID:
20621123
11.

RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.

Walstab J, Hammer C, Lasitschka F, Möller D, Connolly CN, Rappold G, Brüss M, Bönisch H, Niesler B.

J Biol Chem. 2010 Aug 27;285(35):26956-65. doi: 10.1074/jbc.M110.122838. Epub 2010 Jun 3.

12.

Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline.

Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bönisch H.

Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x.

PMID:
20030735
13.

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2009 Sep-Oct;61(5):785-97.

14.

One-year follow-up of the outcome of a randomized controlled trial of a home-based intervention programme for children with autism and developmental delay and their families.

Rickards AL, Walstab JE, Wright-Rossi RA, Simpson J, Reddihough DS.

Child Care Health Dev. 2009 Sep;35(5):593-602. doi: 10.1111/j.1365-2214.2009.00953.x. Epub 2009 Jun 8.

PMID:
19508318
15.

Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors.

Walstab J, Hammer C, Bönisch H, Rappold G, Niesler B.

Pharmacogenet Genomics. 2008 Sep;18(9):793-802. doi: 10.1097/FPC.0b013e3283050117.

PMID:
18698232
16.

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

Kapeller J, Houghton LA, Mönnikes H, Walstab J, Möller D, Bönisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, Atkinson W, Fell C, Büchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B.

Hum Mol Genet. 2008 Oct 1;17(19):2967-77. doi: 10.1093/hmg/ddn195. Epub 2008 Jul 9.

PMID:
18614545
17.

Learning and memory in 5-HT(1A)-receptor mutant mice.

Bert B, Fink H, Rothe J, Walstab J, Bönisch H.

Behav Brain Res. 2008 Dec 16;195(1):78-85. doi: 10.1016/j.bbr.2008.02.028. Epub 2008 Mar 10. Review.

PMID:
18396339
18.

A randomized, controlled trial of a home-based intervention program for children with autism and developmental delay.

Rickards AL, Walstab JE, Wright-Rossi RA, Simpson J, Reddihough DS.

J Dev Behav Pediatr. 2007 Aug;28(4):308-16.

PMID:
17700083
19.

Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.

Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H.

Anal Biochem. 2007 Sep 15;368(2):185-92. Epub 2007 Jun 8.

PMID:
17617370
20.

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.

Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.

Mol Pharmacol. 2007 Jul;72(1):8-17. Epub 2007 Mar 28.

PMID:
17392525
21.

Inpatient care of children with cerebral palsy as perceived by their parents.

Phua V, Reid SM, Walstab JE, Reddihough DS.

J Paediatr Child Health. 2005 Aug;41(8):432-6.

PMID:
16101978
22.

Factors identified during the neonatal period associated with risk of cerebral palsy.

Walstab JE, Bell RJ, Reddihough DS, Brennecke SP, Bessell CK, Beischer NA.

Aust N Z J Obstet Gynaecol. 2004 Aug;44(4):342-6.

PMID:
15282008
23.

Making the research dollar work: outcome from a small research funding body.

Reddihough DS, Walstab JE, McKay MF.

J Paediatr Child Health. 2004 Jan-Feb;40(1-2):73-4. No abstract available.

PMID:
15029880
24.

Maternal antecedents to cerebral palsy in preterm infants.

Walstab J, Bell R, Reddihough D, Brennecke S, Bessell C, Beischerf N.

Dev Med Child Neurol. 2002 Jul;44(7):498. No abstract available.

25.

Antenatal and intrapartum antecedents of cerebral palsy: a case-control study.

Walstab J, Bell R, Reddihough D, Brennecke S, Bessell C, Beischer N.

Aust N Z J Obstet Gynaecol. 2002 May;42(2):138-46.

PMID:
12069139
26.

Cerebral palsy in Victoria, Australia: mortality and causes of death.

Reddihough DS, Baikie G, Walstab JE.

J Paediatr Child Health. 2001 Apr;37(2):183-6.

PMID:
11328476
27.

Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy.

Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA.

Diabetes Care. 1995 Dec;18(12):1550-6.

PMID:
8722050
28.

Update of growth percentiles for infants born in an Australian population.

Guaran RL, Wein P, Sheedy M, Walstab J, Beischer NA.

Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):39-50.

PMID:
8053875
29.

Amniotic fluid insulin values in women with gestational diabetes as a predictor of emerging diabetes mellitus.

Weerasiri T, Riley SF, Sheedy MT, Walstab JE, Wein P.

Aust N Z J Obstet Gynaecol. 1993 Nov;33(4):358-61.

PMID:
8179540
30.

Gestational diabetes and follow-up among immigrant Vietnam-born women.

Henry OA, Beischer NA, Sheedy MT, Walstab JE.

Aust N Z J Obstet Gynaecol. 1993 May;33(2):109-14.

PMID:
8216103
31.

Excessive birth weight and maternal glucose tolerance--a 19-year review.

Shelley-Jones DC, Beischer NA, Sheedy MT, Walstab JE.

Aust N Z J Obstet Gynaecol. 1992 Nov;32(4):318-24.

PMID:
1290427
32.

Obstetric and birthweight differences between Vietnam-born and Australian-born women.

Henry OA, Guaran RL, Petterson CD, Walstab JE.

Med J Aust. 1992 Mar 2;156(5):321-4.

PMID:
1588863
33.

Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia.

Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE.

Diabetes. 1991 Dec;40 Suppl 2:35-8.

PMID:
1748263
34.

Urinary oestriol assay for monitoring fetoplacental function.

Beischer N, Brown J, Parkinson P, Walstab J.

Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):1-8. Review.

PMID:
1872764
35.

Incidence and severity of gestational diabetes in Bahrain and Australia.

el-Shafei AM, Bashmi YA, Beischer NA, Henry OA, Walstab JE.

Aust N Z J Obstet Gynaecol. 1989 Aug;29(3 Pt 1):204-8.

PMID:
2604648
36.

Induction of ovulation with subcutaneous pulsatile gonadotropin-releasing hormone: correlation with body weight and other parameters.

Thomas AK, Mander J, Hale J, Walstab J, Forrest MS.

Fertil Steril. 1989 May;51(5):786-90.

PMID:
2495993
37.

Contribution of prematurity and low birth-weight to neonatal death in Chinese and Western populations.

Drew JH, Beischer NA, Walstab JE, Liang ST, Stronge JM.

Aust N Z J Obstet Gynaecol. 1988 Aug;28(3):190-2.

PMID:
3233081
38.

Survey of hand symptoms in pregnancy.

McLennan HG, Oats JN, Walstab JE.

Med J Aust. 1987 Dec 7-21;147(11-12):542-4.

PMID:
3696040
39.

A reappraisal of urinary oestriol excretion as a screening test in pregnancy.

Beischer NA, Parkinson P, Walstab J.

Aust N Z J Obstet Gynaecol. 1987 Feb;27(1):27-9.

PMID:
3476084
40.

Glucose tolerance in twin pregnancy.

Dwyer PL, Oats JN, Walstab JE, Beischer NA.

Aust N Z J Obstet Gynaecol. 1982 Aug;22(3):131-4. No abstract available.

PMID:
6959610
41.

Rubella screening and vaccination programme at a Melbourne maternity hospital. A five-year review.

Francis BH, Hatherley LI, Walstab JE, Taft LI.

Med J Aust. 1982 Jun 12;1(12):502-4.

PMID:
7099091
42.

Incidences and types of malformations in newborn infants.

Drew JH, Parkinson P, Walstab JE, Beischer NA.

Med J Aust. 1977 Jun 25;1(26):945-9.

PMID:
560620

Supplemental Content

Loading ...
Support Center